Canada Topical Scar Treatment Market Size & Outlook
Canada topical scar treatment market, 2018-2030 (US$M)
Related Markets
Canada topical scar treatment market highlights
- The Canada topical scar treatment market generated a revenue of USD 62.5 million in 2024 and is expected to reach USD 110.3 million by 2030.
- The Canada market is expected to grow at a CAGR of 10% from 2025 to 2030.
- In terms of segment, creams was the largest revenue generating product in 2024.
- Silicon Sheets is the most lucrative product segment registering the fastest growth during the forecast period.
Topical scar treatment market data book summary
| Market revenue in 2024 | USD 62.5 million |
| Market revenue in 2030 | USD 110.3 million |
| Growth rate | 10% (CAGR from 2025 to 2030) |
| Largest segment | Creams |
| Fastest growing segment | Silicon Sheets |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Creams, Gels, Silicon Sheets |
| Key market players worldwide | Smith & Nephew PLC, Lumenis, Merz Pharma, Sonoma Pharmaceuticals Inc, Cynosure, CCA Industries Inc, Newmedical, Molnlycke Health Care, Suneva Medical, Pacific World Corporation, Perrigo Co PLC, Enaltus, SCAR |
Other key industry trends
- In terms of revenue, Canada accounted for 3.7% of the global topical scar treatment market in 2024.
- Country-wise, China is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. topical scar treatment market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 620.9 million by 2030.
Creams was the largest segment with a revenue share of 39.52% in 2024. Horizon Databook has segmented the Canada topical scar treatment market based on creams, gels, silicon sheets covering the revenue growth of each sub-segment from 2018 to 2030.
The Canada topical scar treatment market is expanding, partly due to the high prevalence of road accidents, which often result in scarring from injuries. According to a 2023 report by the International Transport Forum, Canada experienced 1,934 road accident fatalities in 2022, marking a 9.4% increase from the previous year and the second-highest death toll in a decade.
In response, innovation and clinical research are driving advancements in topical scar treatments. Companies are investing in clinically tested formulations that incorporate advanced ingredients like silicone-based gels, growth factors, and mineral sunscreens to improve scar healing and reduce visibility.
In January 2021, Vancouver-based BirchBioMed Inc. announced statistically significant, positive outcomes from a double-blind study evaluating the safety and effectiveness of its topical FS2 treatment for keloid scars. FS2, the active ingredient in BirchBioMed's FS2 cream, has demonstrated an ability to inhibit collagen formation, a key factor in scar development.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Topical scar treatment market Scope
Topical scar treatment market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada topical scar treatment market report size, by product, 2018-2030 (US$M)
Canada Topical scar treatment market Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
